Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Fiscal 2009 funded

This article was originally published in The Tan Sheet

Executive Summary

Congress passes and President Obama signs the Omnibus Appropriations Act of 2009 March 11 to fund the bulk of government agencies - including FDA - through the end of fiscal 2009. Under the $410 billion package, H.R. 1105, FDA is provided $2.6 billion for fiscal 2009 (1"The Tan Sheet" March 2, 2009, p. 9)

You may also be interested in...

Obama Budget Links Proposed User Fees To Improving Food Safety

The nearly $260 million increase President Obama requests for FDA's food safety operations includes $75 million in new user fees

Congress’ Omnibus Language Seeks FDA Progress Reports On Spending

Members of Congress want detailed quarterly updates from FDA on how the agency uses its 2009 appropriation, according to a joint explanatory statement accompanying the omnibus spending bill

EU Regulatory Round-Up, February 2020: Brexit And Swixit Threaten Huge Disruption Amidst MDR Uncertainty

Complying with the EU’s new Medical Device Regulation would be hard enough. But more layers of uncertainty – especially Brexit and Swixit ̶ mean European medtech is navigating very turbulent waters right now.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts